Company intelligence / Profile preview

Beijing Xinghao Pharmaceutical

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Xinghao Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of chemical drugs, with a particular emphasis on anti-viral therapies. The company is well-known for its portfolio of treatments for chronic Hepatitis B, including generic and improved versions of nucleoside analogs. Beyond its commercial products, Xinghao Pharmaceutical engages in the development of new drug delivery systems and high-end generic formulations. The company operates integrated facilities for R&D and manufacturing to support its domestic market presence in China.

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

oseltamivir phosphate

Approved

Beyond the preview

Go deeper on Beijing Xinghao Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Xinghao Pharmaceutical.

Explore the full profile